CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and software solutions, today announced that revenues for the second quarter of fiscal 2009 were $92,708,000, compared to revenues in the second quarter of last year of $99,160,000, a decline of 7%. Revenue results reflected a negative foreign exchange impact of nearly $5 million, compared to the second quarter of fiscal 2008. Net income for the quarter was $1,782,000, compared to $5,654,000 for the prior-year quarter. Diluted earnings per share were $0.08, compared to $0.27 in the prior-year quarter. Backlog at the end of the second quarter was approximately $7.8 million.
